Cite
HARVARD Citation
Umeda, N. et al. (2014). AB0136 Clinical Aspects and Pathogenicity of Anti-Cyclic Citrullinated Glucose-6-Phospate Isomerase Peptide (CCG) Antibodies in Patients with Rheumatoid Arthritis. Annals of the rheumatic diseases. p. 848. [Online].